JeffreyS.EshlemanMD(He/Him)

PubMed

• 6 citations
  In Reply to Drs. Larson and Sahgal
  Paul D. Brown, Andrew Y. Kee, Jeffrey S. Eshleman, John B. Fiveash> ;International Journal of Radiation Oncology, Biology, Physics. 2009 Sep 1
• 67 citations
  Radioactive seed migration to the chest after transperineal interstitial prostate brachytherapy: extraprostatic seed placement correlates with migration.
  Jeffrey S. Eshleman, Brian J. Davis, Thomas M. Pisansky, Torrence M. Wilson, Michael G. Haddock, Bernard F. King, C.H. Darby, Wayne N. LaJoie, Ann L. Oberg> ;International Journal of Radiation Oncology, Biology, Physics. 2004 Jun 1
• 167 citations
  Inhibition of the mammalian target of rapamycin sensitizes U87 xenografts to fractionated radiation therapy.
  Jeffrey S. Eshleman, Brett L. Carlson, Ann C. Mladek, Brian D. Kastner, Kathleen L. Shide, Jann N. Sarkaria> ;Cancer Research. 2002 Dec 15
• 44 citations
  ATM as a target for novel radiosensitizers
  Jann N. Sarkaria, Jeffrey S. Eshleman> ;Seminars in Radiation Oncology. 2001 Oct 1
• 46 citations
  PROSTATE BRACHYTHERAPY SEED MIGRATION TO THE RIGHT VENTRICLE FOUND AT AUTOPSY FOLLOWING ACUTE CARDIAC DYSRHYTHMIA
  Brian J. Davis, Eric A. Pfeifer, Torrence M. Wilson, Bernard F. King, Jeffrey S. Eshleman, Thomas M. Pisansky> ;The Journal of Urology. 2000 Nov 1
• 42 citations
  An analysis of facial nerve function in irradiated and unirradiated facial nerve grafts.
  Paul D. Brown, Jeffrey S. Eshleman, Robert L. Foote, Scott E. Strome> ;International Journal of Radiation Oncology, Biology, Physics. 1999 Jan 1
• Join now to see all

Journal Articles

• The Cyberknife® M6™ Radiosurgery System  
  Eshleman jS, J Lanc Gen, 2013
• A new tool to fight cancer – Tomotherapy.  
  Eshleman JS, J Lanc Gen, 9/1/2009
• Radioactive seed migration to the chest following transperineal interstitial permanent prostate brachytherapy: extraprostatic seed placement correlates with migration.  
  Eshleman JS, Davis BJ, Pisansky TM, Wilson TM, Haddock MG, King BF, Darby CH, LaJoie WN, Oberg AL, Int J Radiat Oncol Biol Phys, 1/1/2004
• Inhibition of the mammalian target of rapamycin sensitizes U87 xenografts to fractionated radiation therapy.  
  Eshleman JS, Carlson BL, Mladek AC, Kastner BD, Shide KL, Sarkaria JN, Cancer Research, 1/1/2002
• ATM as a target for novel radiosensitizers,  
  Sarkaria JN, Eshleman JS, Seminars in Radiation Oncology, 1/1/2001
• Prostate brachytherapy seed migration to the right ventricle found at autopsy following acute cardiac dysrhythmia  
  Davis BJ, Pfeifer EA, Wilson TM, King BF, Eshleman JS, and Pisansky TM, Journal of Urology, 1/1/2000
• An analysis of facial nerve function in irradiated and unirradiated facial nerve grafts  
  Brown PD, Eshleman JS, Foote, RL, and Strome, SE, International Journal of Radiation Oncology, Biology, Physics, 1/1/2000
• External beam radiation enhances antibody mediated radiocytotoxicity in human glioma cells in vitro  
  Bender H, Emrich JG, Eshleman J, Chu MA, Steplewski Z, Biersack HJ, Brady LW, Anticancer Research, 1/1/1997
• In vitro evaluation of iodine-125-labeled monoclonal antibody (MAb 425) in human high-grade glioma cells  
  Emrich JG, Bender H, Class R, Eshleman J, Miyamoto C, Brady LW, American Journal of Clinical Oncology, 1/1/1996
• Enhancement of monoclonal antibody efficacy: the effect of external beam radiation.  
  Bender H, Emrich JG, Eshleman J, Chu MA, Steplewski Z, Biersack HJ, Brady LW, Hybridoma, 1/1/1995
• Indium-111-labeled anti-EGFr-425 scintigraphy in the detection of malignant gliomas  
  Dadparvar S, Krishna L, Miyamoto C, Brady LW, Brown SJ, Bender H, Slizofski WJ, Eshleman J, Chevres A, Woo DV, Cancer, 1/1/1994
• Malignant astrocytomas treated with Iodine-125 labeled monoclonal antibody 425 against epidermal growth factor receptor: a phase II trial  
  Brady LW, Miyamoto CT, Woo DV, Rackover M, Emrich J, Bender H, Dadparvar S, Steplewski Z, Koprowski H, Black P, Lazarro B, Nair S, McCormack T, Nieves J, Morabito M, E..., International Journal of Radiation Oncology, Biology, Physics, 1/1/1992
• Join now to see all

Abstracts/Posters

• Retrospective Study of Ipsilateral Breast Tumor Recurrence in Patients Undergoing Accelerated Partial Breast Irradiation Delivered by Balloon Brachytherapy in a Commun...
  Eshleman, JS, Shuman, TP, Berkenstock, KG, Singapuri, KP, Newman, PG, Parker,SL, Chory*,ET, Beyer*,FC, Horst, MA, Dodge, DG., International Journal of Radiation Oncology*Biology*Physics, Volume 87, Issue 2, Supplement, 1, 2013
• Inhibition of the mammalian target of rapamycin enhances the efficacy of fractionated radiation in U87 xenograft and spheroid model systems.
  Sarkaria JN, Mladek AC, Carlson BL, Eshleman JS, International 6th Wolfsberg Meeting, Ermatingen Switzerland, 6/8/2002
• Rapamycin Sensitizes U87 Xenografts to Fractionated Radiation Therapy
  Sarkaria JN, Carlson BL, Mladek AC, , Eshleman JS, Society of Neurologic Oncology Annual Meeting, 1/1/2002
• Continuous inhibition of mTOR enhances the efficacy of radiation therapy in U87 glioma xenografts.
  Sarkaria JN, Eshleman JS, Carlson BL, Mladek AC, Shide KL, Kastner, BD, Radiation Research Society Annual Meeting, 1/1/2002
• Rapamycin increases the efficacy of fractionated radiation in malignant glioma cells.
  Sarkaria JN, Eshleman, JS, Kastner BD, Shide KL, ESTRO Annual Meeting, 11/1/2001
• Development of a substrate screen for hChk1 and hChk2 kinase activity.
  Eshleman JS, Leitriz DF, Chen J, Sarkaria JN, Radiation Research Society Annual Meeting, San Juan, Puerto Rico, 4/20/2001
• Does adjuvant radiotherapy for primary adenoid cystic carcinoma of the parotid gland reduce the risk for loco-regional recurrence and associated morbidity?
  Eshleman JS, Brown PB, Strome SE, Foote RL, International Journal of Radiation Oncology Biology Physics, 1/1/2000
• An analysis of facial nerve function in irradiated and unirradiated facial nerve grafts.
  Brown PD, Eshleman JS, Foote RF, Strome SE, International Journal of Radiation Oncology, Biology, and Physics, 1/1/1999
• Immunoradiotherapy with 125-I labeled monoclonal antibodies in advanced neoplastic diseases.
  Guerrieri P, Brady LW, Miyamoto C, Rackover M, Emrich J, Woo D, Bender H, Eshleman J, Steplewski Z, Koprowshi H, International Journal of Radiation Oncology Biology Physics, 1/1/1994
• Utilization of iodine-125 labeled monoclonal antibodies in the management of primary and recurrent high grade astrocytomas.
  Miyamoto CT, Brady LW, Rackover M, Emrich J, Woo D, Bender H, Class R, Eshleman J, Snelling L, Steplewski Z, Koprowski H, Black P, McCormack T, Nair S, Dadparvar S, De..., 79th Annual Scientific Program of the Radiological Society of North America, Chicago, IL, 11/28/1993
• Increased delivery of 125-iodine murine monoclonal antibody against the epidermal growth factor receptor to human high grade glioma cells in vitro.
  Emrich JG, Bender H, Class R, Eshleman J, Brady LW, Third Drug Discovery and Development Symposium, 1/1/1993
• A semi-automated colorimetric methylene blue assay for cellular viability following radiation and chemotherapy.
  Chu AM, Eshleman J, Radiation Research Society, 40th Annual Meeting, 1/1/1992
• Utilization of the radiolabeled MAB 425/EMD 55 900 in the management of high grade gliomas.
  Brady LW, Miyamoto CT, Bender H, Rackover M, Emrich J, Eshleman J, Woo D, Morabito M, Steplewski Z, Koprowski H, Black P, International Journal of Radiation Oncology Biology Physics., 1/1/1992
• Retrospective study of ipsilateral breast tumor recurrence in patients undergoing accelerated partial breast irradition with mammosite in a community setting.
  Eshleman, JS, Shuman
• Radioactive seed migration tot he chest following transperineal interstitial brachytherapy for early stage prostate carcinoma.
  Eshleman JS, Davis BJ, Wilson TM, LaJoie WN, King BF, Darby CH, Oberg AL, Haddock MG, Pisansky TM, International Journal of Radiation Oncology, Biology, Physics
• Join now to see all

Lectures

• Cyberknife Radiosurgery for Prostate Cancer 
  Lancaster General Suburban Outpatient Pavilion, Lancaster, PA - 3/1/2013
• Proposed Changes to the National Cancer Institute’s Cooperative Group Structure 
  Lancaster, PA - 9/1/2012
• Insider's Event; Cyberknife & Other New Radiation Technologies 
  Lancaster General Hospital - 8/1/2012
• Radiotherapy for Prostate Cancer 
  Lancaster General Suburban Outpatient Pavilion, Lancaster, PA - 1/1/2012
• Introduction to Radiation Oncology 
  Lancaster General Hospital - 10/1/2011
• The Future of Radiation Oncology Technology 
  Lancaster General Hospital - 5/1/2011
• Extracranial Stereotactic Radiosurgery for Early Stage Non-small Cell Lung Cancers 
  6/1/2010
• Partial Breast Radiotherapy 
  Inn at Mazzi's Restaurant, Leola, PA - 5/1/2009
• Update on Clinical Trials Results for Bexxar Radioimmunotherapy, 
  Lancaster General Suburban Outpatient Pavilion, Lancaster, PA - 1/1/2009
• Introduction to Tomotherapy 
  Log Cabin Restaurant - 11/1/2006
• Palliative Radiotherapy for Bone Metastases 
  Strawberry Hill Restaurant - 10/1/2006
• Radioimmunotherapy for Non-Hodgkin’s Lymphoma 
  Carr’s Restaurant, Lancaster, PA - 6/1/2006
• New Advances in Radiation Oncology 
  Trinity Church, Lancaster, PA - 3/1/2006
• Breast Cancer: New Radiotherapeutic Options 
  Lancaster General College of Nursing - 11/1/2005
• Breast Cancer: Partial Breast Radiotherapy with the New Mammosite Catheter 
  10/1/2005
• Introduction to IMRT 
  Lancaster General Suburban Outpatient Pavilion - 10/1/2005
• Radiotherapy for Primary Brain Tumors 
  Lancaster General Suburban Outpatient Pavilion - 9/1/2005
• Focus on Health: Breast Cancer 
  Lancaster General Hospital, Lancaster, PA - 5/1/2005
• Guest panelist, American Cancer Society Survivor’s Conference 
  Host Resort, Lancaster, PA - 4/1/2005
• Bexxar Radioimmunotherapy 
  Strawberry Hill Restaurant, Lancaster, PA - 1/1/2005
• Breast Cancer 
  Lancaster, PA - 8/1/2004
• Prostate Cancer Overview 
  8/1/2004
• Prostate Brachytherapy 
  Dayton, OH - 11/1/2003
• Overview of Radiation Oncology 
  Miami Valley Hospital, Dayton, OH - 4/1/2003
• Overview of Radiotherapy for High Grade Gliomas 
  Mayo Clinic, Rochester, MN - 4/1/2000
• Join now to see all